Comparison of Robotic and Laparoscopic Partial Nephrectomy in Robotic Surgery Era
Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2019, Vol 18, Issue 4
Abstract
Objective: To compare the results of robotic partial nephrectomy (RPN) and laparoscopic partial nephrectomy (LPN) operations and to determine whether they have any superiority to each other in terms of oncological and functional outcomes. Materials and Methods: The data of patients who underwent partial nephrectomy due to renal tumor in our clinic were evaluated retrospectively. The data included demographic information, operative technique, tumor size, operative time, duration of warm ischemia, amount of intraoperative bleeding, length of hospital stay and complications. Results: A total of 60 patients were included in the study. There was no significant difference between age (52.5±13.3 years vs 50.1±12.4 years, p=0.48), body mass index (26.9±3.7 vs 27.3±3.3 kg/m2, p=0.69) and tumor size (3.2±1.4 cm vs 3.4±1.2 cm, p=0.79) of patients who underwent LPN and RPN. The mean operative time (194.5±44.6 min vs 203.3±22.2 min, p<0.001) and length of hospitalization (5±1.4 days vs 6.2±2.1 days, p=0.009) were significantly shorter in the RPN group. Although intraoperative bleeding was less in RPN patients, it was not statistically significant (p=0.065). Similarly, the duration of warm ischemia was lower in RPN patients than in LPN patients, but it was not statistically significant (14.3±7.8 min vs 16.3±7.3 min, p=0.298). Conclusion: RPN and LPN, which are minimally invasive surgical treatment options, can be used safely in the treatment of kidney tumors. RPN can be recommended to patients for early return to daily life.
Authors and Affiliations
Ekrem Güner, Selçuk Şahin
Keywords
Related Articles
- EP ID EP665790
- DOI 10.4274/uob.galenos.2019.1306
- Views 107
- Downloads 0
Omalizumab in chronic urticaria: A comprehensive review
Omalizumab is a humanized monoclonal anti-immunoglobulin E which is originally developed for the treatment of allergic respiratory disorders, but has been approved for the treatment of antihistamine-resistant chronic spo...
The role of uric acid in metabolic syndrome in patients with psoriasis
Background and Design: Psoriasis patients have increased risk of obesity, metabolic syndrome and cardiovascular disease. Uric acid is a metabolic marker associated with metabolic syndrome and cardiovascular diseases. Uri...
Successful treatment of confluent and reticulated papillomatosis with tetracycline and mupirocin
Confluent and reticulated papillomatosis characterized by hyperkeratotic-pigmented papules is a rare dermatosis, which tends to settle in seborrheic areas. Some cutaneous disorders share the same features. Herein, we rep...
Evaluation of hearing with pure-tone audiometry in alopecia areata patients
Background and Design: We aimed to evaluate whether alopecia areata (AA) patients had hearing loss with pure-tone audiometry. Materials and Methods: In the study, 48 patients with AA and 39 healthy volunteers were inclu...
Ustekinumab associated bullous pemphigoid in a psoriasis patient and a review of the literature
Ustekinumab is a Food and Drug Administration-approved (2009) novel treatment for psoriasis patients. This anti-interleukin-12/23p40 monoclonal antibody is effective in the treatment of plaque psoriasis and psoriatic art...